India has proposed reciprocal zero tariffs on steel, auto components, and pharmaceuticals for a limited quantity of US imports during recent trade negotiations.
This offer aims to accelerate a bilateral trade deal before the end of Trump’s 90-day tariff pause.
The US has raised concerns about India’s Quality Control Orders, which it views as non-tariff barriers.
India has expressed willingness to reconsider these standards in sectors like medical devices and chemicals.